Nithi said 14,326,065 Sinopharm doses have been administered in Thailand between June 25 to December 22, and of them, 7,175,786 are the first jab and 7,150,279 the second.

&ldquo;After the first jab, only 27,173 people or 0.38 per cent developed mild side effects in the first 30 minutes, 44,798 people or 0.62 per cent developed side effects one day later and 22,212 people or 0.31 per cent showed symptoms seven days later,&quot; he explained.

Side effects included headache, muscle ache, fatigue, soreness in the jab site and fever.

&quot;After the second jab, 4,162 people or 0.06 per cent developed side effects in the first 30 minutes, 23,047 people or 0.32 per cent one day after the jab, and 15,039 people or 0.21 per cent after seven days.&rdquo;

So far, he said, 23 people have died and 17 developed severe conditions after getting a Sinopharm jab.

Related stories:

<ul>
	<li><a href="https://www.nationthailand.com/in-focus/40009804">China donates 200,000 Sinopharm doses</a></li>
	<li><a href="https://www.nationthailand.com/in-focus/40008772">Thailand will go well beyond its target of 100 million Covid-19 vaccine doses by end-2021</a></li>
	<li><a href="https://www.nationthailand.com/international/40008680">UK to add China&#39;s Sinovac, Sinopharm to approved COVID-19 vaccine list</a></li>
</ul>

Sinopharm Covid-19 shots generally safe, says Chulabhorn Royal Academy official

Few recipients of the inactive Sinopharm Covid-19 vaccine developed serious side effects, Chulabhorn Royal Academy’s secretary-general Dr Nithi Mahanonda said in a Facebook post on Friday.